IOL Chemicals and Pharmaceuticals Ltd: History, Latest Updates, Milestones, Subsidiaries and Share Price
Introduction
IOL Chemicals and Pharmaceuticals Ltd is a leading player in the pharmaceutical and specialty chemicals industry, known for its strong presence in the Active Pharmaceutical Ingredient (API) segment. Established in 1986, the company has grown into a key manufacturer of Ibuprofen, one of the most widely used pain-relief drugs globally. With an integrated business model and advanced production facilities, IOL Chemicals has consistently expanded its market share in both domestic and international markets. Investors keen on the IOL Chemicals share price closely monitor its performance, as the company continues to achieve significant milestones, introduce innovative products, and strengthen its position in the pharmaceutical and chemical sectors.
IOL Chemicals and Pharmaceuticals Ltd moves in 2025:
- Financial Performance: In the quarter ending September 2024, IOL Chemicals and Pharmaceuticals Ltd reported net sales of INR 525.75 crore, a 3.59% decrease compared to the same period the previous year. Despite this, investors continue to track the IOL Chemicals share price for potential recovery.
- Profit Margins: The company's net profit margin for the same quarter was 3.60%, reflecting a 47.51% decline year-over-year. Market analysts believe that fluctuations in the IOL Chemicals share price may be influenced by these profitability trends.
- Product Portfolio & Market Position: IOL Chemicals remains a dominant global producer of Ibuprofen, holding a 35% market share with an annual production capacity of 12,000 TPA. This strong market presence plays a key role in investor sentiment and the movement of the IOL Chemicals share price over time.
These key developments highlight the company's recent financial performance and its impact on the stock market.
Evolution of IOL Chemicals and Pharmaceuticals Ltd: From Past to Present:
Past:
- IOL Chemicals and Pharmaceuticals Ltd was established in 1986 with a vision to become a key player in the chemical and pharmaceutical sectors. Initially, the company focused on manufacturing bulk chemicals, gradually expanding its capabilities to include Active Pharmaceutical Ingredients (APIs). A major breakthrough came when IOL Chemicals became one of the leading global manufacturers of Ibuprofen, cementing its position in the pharmaceutical industry. Over the years, strategic investments in research, production facilities, and quality control allowed the company to build a strong foundation and gain a competitive edge in both domestic and international markets.
Present:
- Today, IOL Chemicals and Pharmaceuticals Ltd stands as a major integrated manufacturer of APIs and specialty chemicals, serving global markets. With a production capacity of 12,000 TPA for Ibuprofen, the company holds a significant market share worldwide. It has diversified its product portfolio, focusing on sustainability and innovation to meet evolving industry demands. Investors closely monitor the IOL Chemicals share price, reflecting its strong financial performance and market presence. Through continuous expansion, technological advancements, and regulatory compliance, IOL Chemicals continues to reinforce its position as a key player in the pharmaceutical and chemical sectors.
| Name | IOL Chemicals and Pharmaceuticals Ltd |
| Founded year | 1986 |
| Chairman | Rajender Mohan Malla (Chairman & Independent Director ) |
| Headquarters | Punjab, India |
| Sector | Healthcare |
| Nse code | IOLCP |
| Bse code | 524164 |
Timeline of IOL Chemicals and Pharmaceuticals Ltd :
| Year | Milestone |
| 1986 | Incorporated with an Acetic Acid Plant. |
| 1996 | Commencement of Ethyl Acetate Plant. |
| 1999 | Commencement of Acetic Anhydride Plant. |
| 2000 | Commencement of Ibuprofen Unit-1. |
| 2007 | Established Unit-1 dedicated to Ibuprofen. |
| 2007 | Established a multi-fuel captive co-generation power plant of 4MW capacity. |
| 2009 | Commencement of Iso Butyl Benzene, Mono Chloro Acetic Acid, and Acetyl Chloride Plant, leading to backward integration to Ibuprofen. |
| 2010 | IOL secures its listing on the National Stock Exchange (NSE). |
| 2010 | Established a multi-fuel captive co-generation power plant of 13MW capacity. |
| 2012 | Commencement of Unit-2 for multi-product manufacturing. |
| 2013 | Received EU-GMP certification. |
| 2015 | Received USFDA EIR for Ibuprofen. |
| 2016 | Commencement of Unit-3 for new product launches. |
| 2017 | Conversion of Unit-2 into a dedicated facility for Ibuprofen. |
| 2018 | Established Unit-4 dedicated to Metformin Hydrochloride. |
| 2018 | Established Unit-5 dedicated to Clopidogrel Bisulfate Form II & Fenofibrate. |
| 2019 | Established Unit-6 dedicated to Pantoprazole Sodium. |
| 2020 | Established Unit-7 dedicated to Metformin. |
| 2021 | Established Unit-8 for Multi Products. |
Inside IOL Chemicals and Pharmaceuticals Ltd:
Corporate actions:
- IOL Chemicals and Pharmaceuticals Ltd. has declared seven dividends since March 18, 2020.
- In the past 12 months, the company has declared an equity dividend of Rs. 4.00 per share.
- At the current IOL Chemicals share price of Rs. 100.1300 as on 9 October 2025, the dividend yield stands at 3.99%.
Main News:
- In December 2024, IOL Chemicals and Pharmaceuticals has announced its financial results for the third quarter ended December 31, 2024 (Q3FY25).
The company reported an 11.54% decline in net profit, which stood at Rs 20.55 crore for Q3FY25, compared to Rs 23.23 crore in the same quarter last year. Its total income saw a slight dip, amounting to Rs 527.37 crore in Q3FY25, down from Rs 528.77 crore in the corresponding quarter of the previous year.
On a consolidated basis, the company's net profit declined by 11.05% to Rs 20.53 crore for the quarter ended December 31, 2024, compared to Rs 23.08 crore in the same period last year. Meanwhile, total income remained nearly stable at Rs 527.37 crore in Q3FY25, as against Rs 528.77 crore in the corresponding quarter of the previous year.
Current Radico Share Price NSE:
| COMPANY NAME | SECTOR | SHARE PRICE LINK |
| IOL Chemicals and Pharmaceuticals Ltd | Healthcare | IOL Chemicals Live Stock Price |
Achievements and Milestones:
- IOL Chemicals and Pharmaceuticals Ltd. is recognized for its commitment to energy conservation and responsible chemical management.
- The company has received multiple National Energy Conservation Awards in the Drugs & Pharmaceuticals sector from the Ministry of Power, Government of India for reducing energy consumption.
- It has been awarded the "Responsible Care" logo by the Indian Chemical Council (ICC) for adhering to safe and sustainable chemical handling practices.
Conclusion
In conclusion, IOL Chemicals and Pharmaceuticals Ltd has consistently demonstrated resilience and innovation in the pharmaceutical and specialty chemicals industry. With a strong market presence, strategic expansions, and commitment to sustainability, the company continues to drive growth despite financial fluctuations. As investors closely track the IOL Chemicals share price, its strong fundamentals and market leadership in API manufacturing position it well for long-term success.
Investors should closely monitor the company's performance, including its financial results, market share trends, and strategic initiatives, to assess its future prospects and their potential impact on the IOL Share Price Today.
To gain more information on IOL Chemicals Live Stock Price NSE, the latest news, and stock analysis, visit Enrich Money. Enrich Money provides a free demat account with no annual charges and it's the best trading app for beginners in India.
Frequently Asked Questions:
Where can I find real-time updates on the IOL chemicals share price?
Explore the latest IOL chemicals share price and real-time stock price updates on Enrich Money's stock analysis page here.
What has been the peak IOL chemicals share price in the last 52 weeks?
52 Week's highest IOL chemicals share is Rs 126.66, while 52 Week's lowest IOL chemicals share price is Rs. 57.50
Is IOL Chemicals a good investment based on its share price trends?
The investment potential of IOL Chemicals share price depends on various factors, such as historical price trends, growth prospects in the pharmaceutical and chemical sectors, and the company’s financial health. Investors should analyze earnings reports, industry developments, and market conditions before making investment decisions.
How has the IOL Chemicals share price performed in recent years?
Over the past three years, the IOL Chemicals share price has decreased by approximately 11.88% on the BSE.
What are the key financial metrics influencing the IOL Chemicals share price?
Key financial metrics impacting the IOL Chemicals share price include a market capitalization of Rs. 1,974.87 crore, a price-to-earnings (P/E) ratio of 20.36, and a price-to-book (P/B) ratio of 0.84 as of February 14, 2025. For the quarter ending September 2024, the company recorded a net profit of Rs. 19.15 crore, with a total income of Rs. 532.18 crore.
Disclaimer: This blog is dedicated exclusively for educational purposes. Please note that the securities and investments mentioned here are provided for informative purposes only and should not be construed as recommendations. Kindly ensure thorough research prior to making any investment decisions. Participation in the securities market carries inherent risks, and it's important to carefully review all associated documents before committing to investments. Please be aware that the attainment of investment objectives is not guaranteed. It's important to note that the past performance of securities and instruments does not reliably predict future performance.
